Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC)

被引：9
|
作者：
Szczylik, C.
Porta, C.
Bracarda, S.
Hawkins, R.
Bjarnason, G. A.
Oudard, S.
Lee, S.
Carteni, G.
Hariharan, S.
Gore, M. E.
机构：
[1] Mil Med Inst, Warsaw, Poland
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Azienda Osped Perugia, Perugia, Italy
[4] Christie Hosp, Manchester, Lancs, England
[5] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[6] Hop Europeen Georges Pompidou, Paris, France
[7] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[8] Pfizer Inc, New York, NY USA
[9] Royal Marsden Hosp NHS Trust, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SUNITINIB IN PATIENTS (PTS) WITH OR WITHOUT PRIOR NEPHRECTOMY IN AN EXPANDED-ACCESS STUDY OF METASTATIC RENAL CELL CARCINOMA (MRCC)
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Kee, S. H.
    Carteni, G.
    Hariharan, S.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [2] SUNITINIB GLOBAL EXPANDED-ACCESS TRIAL IN METASTATIC RENAL CELL CARCINOMA (MRCC) - FINAL RESULTS
    Gore, M. E.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Crino, L.
    Kim, T. M.
    Fly, K.
    Szczylik, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 271 - 271
  • [3] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final US results
    Hutson, T. E.
    Dudek, A. Z.
    Fishman, M. N.
    Thompson, J. A.
    Agarwal, N.
    George, D. J.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Dreicer, R.
    BJU INTERNATIONAL, 2013, 112 : 4 - 5
  • [4] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final Italian results
    Sternberg, C.
    Bracarda, S.
    Carteni, G.
    Lo Re, G.
    Ruggeri, E. M.
    Masini, C.
    Fly, K.
    Zhang, K.
    Hariharan, S.
    Capaccetti, B.
    Porta, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S644 - S644
  • [5] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final results from Spain
    Castellano, D.
    Garcia del Muro, X.
    Climent, M. A.
    Maroto, P.
    Perez-Gracia, J. L.
    Lopez-Vivanco, G.
    Zhang, K.
    Fly, K.
    Hariharan, S.
    Anton-Aparicio, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S666 - S666
  • [6] Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis
    Gore, M. E.
    Porta, C.
    Oudard, S.
    Bjarnason, G.
    Castellano, D.
    Szczylik, C.
    Mainwaring, P. N.
    Schoffski, P.
    Rini, B. I.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Sunitinib in metastatic renal cell carcinoma (mRCC) patients (pts) with brain metastases (mets): data from an expanded access trial
    Hariharan, S.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Short- and long-term safety with sunitinib in an expanded access trial in metastatic renal cell carcinoma (mRCC)
    Porta, C.
    Szczylik, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis
    Gore, M.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 299 - 299
  • [10] Sunitinib in patients (pts) from Latin America: Final results of the expanded-access trial in metastatic renal cell carcinoma (mRCC)
    Barrios, C. H.
    Herchenhorn, D.
    Chacon, M.
    Cabrera-Galeana, P.
    Monaco, M.
    Sajben, R.
    Zhang, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S652 - S652
12345